Neural Networks
Издатель: Elsevier · ISSN 0893-6080 · 93 статей
-
Christopher D. Porada, PhD (1969–2026): In memoriam
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Roland W. Herzog, Graça Almeida-Porada
-
Recent progress in the rational design of mRNA vaccines
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Zijia Guo, Jiayan Fu, Luna Ran, Nengcheng Bao, Yadong Wang, Haiyang Dong, Xiaofeng Yang, Yongfeng Jin
-
Addressing the package: Cell-specific gene delivery using lentiviral vectors
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Anjali Shrivastava, Felix L. Warnecke, Juliane W. Schott, Michael Morgan, Axel Schambach
-
Efficient and safe transduction of cochlear outer hair cells in adult mice with AAV2.7m8-Myo15
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Weilong Wang, Xi Dai, Danqi Wang, Pengwei Ma, Wei Gao, Xiaoxiang Xu, Jieyu Qi, Renjie Chai, Zuhong He
-
In vivo -directed evolution identifies AAV-WM04 as a next-generation vector for potent and sustained hearing restoration in DFNB9
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Yong Tao, Cenfeng Chu, Zhenzhe Cheng, Shan Yin, Yilin Sun, Ying Chen, Huifang Zhang, Shuyue Bao, Boyu Yang, Baoyi Feng, Xianyu Huang, Yao Lu,...
-
Identification of AAV vector integration sites in primary human and macaque hepatocytes in vivo and analysis of oncogenic risk
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Suzanne Scott, Claus V. Hallwirth, Natsuki Sasaki, Sharon C. Cunningham, Erhua Zhu, Neeta Khandekar, Eddy Kizana, Julien Baruteau, Paul Gissen,...
-
A modified cyclosporine enhances lentivector transduction ex vivo and in vivo by degrading IFITM3
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Dara Annett, Bethan J. Critchley, Kate L. Morling, Ben Graham, Valeria Pingitore, Thomas E. Whittaker, Nada Kurdi, Justin Warne, Shefta E. Moula,...
-
In vivo engineering of T cells with a synthetic cytokine receptor enables selective enrichment and expansion of anti-CD22 CAR T cells
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Travis J. Friesen, Alyssa Sheih, Nikole Perdue, Nolan G. Ericson, Dillon Jarrell, Ashley M. Yingst, Christopher J. Nicolai, Timothy Gervascio,...
-
CAR T cells secreting anti-EpCAM bispecific T cell engagers overcome tumor heterogeneity in targeting epithelial-originated carcinomas
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Bei Wang, Wen-Hsin Lee, Yuanyu Hu, Yvonne Yee Chin Yeap, Eve Zi Xian Ngoh, Mun Kuen Soh, Siti Nazihah Mohd Salleh, Nur Izzah Nabilah Binte...
-
Injectable bioinstructive microfoam for rapid bedside/ in vivo programming of CAR-T cells
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Sirkka B. Stephan, Carrie L. Cummings, Katelyn Fitzgerald, Hoku West-Foyle, Eric J. Cavanaugh, Inci Cevher Zeytin, Stefan Radtke, Hans-Peter...
-
Inhaled nanosilica orchestrates a pulmonary macrophage-NK cell axis for memory-like NK programming toward synergistic cancer immunotherapy
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Feng Yuan, Qi Li, Yingnan Liu, Fangfang Liu, Wenhe Luo, Qingle Song, Yanqiao Zeng, Jiacheng Bi, Guofang Zhang, Yang Li
-
A singular base-editing platform for polyfunctional multiplex engineering of immune cells
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Joseph G. Skeate, Nicholas J. Slipek, Walker S. Lahr, Shambojit Roy, Bryce J. Wick, Bibekananda Kar, Jae-Woong Chang, Erin M. Stelljes,...
-
Repurposing base editors for targeted knockin and simultaneous multiplex knockouts to generate allo-CAR T cells with minimal translocations
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Viktor Glaser, Lily Jo Becker, Carla Fuster-García, Eric Jackson Aird, Luis Huth, Ana-Maria Nitulescu, Yaolin Pu, Isabell Kassing, Laura Marie...
-
A combinatorial EV-miRNA signature mediates the anti-tumoral activity of NFAT3-regulated extracellular vesicles in aggressive cancers
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Guénolé Tossou, Nadia Ourari, Maëlle Ralu, Alexandre Montanede, Frédéric Guaddachi, Babette Beher, Manon Paul, Emilie Ouanounou, Morgane le Bras,...
-
Precise hepatic base editing of ASGR1 enables robust and durable LDLR-independent lipid lowering in vivo
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Yaofeng Hou, Yaxin Luo, Jiabei Chen, Xindi Shang, Yan Chang, Xianfang Zhang, Yan Ding, Wenwen Zhao, Chengfeng Ding, Xuan Feng, Jia Chen, Jianfeng...
-
Development of recombinant anti-TLR2 antibodies and PLGA nanoparticle-based gene therapy for the treatment of neuropathic pain
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Subeen Lee, Jaekyung Jeon, Hyunji Lee, Ellane Eda Barcelon, Jinpyo Hong, Sung Joong Lee
-
Lineage-tailored vesicles from human retinal ganglion-like cells drive metabolic homeostasis and bioenergetic recovery in glaucoma
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Sandeep Kumar Vishwakarma, Mallikarjuna Rao Gedda, Stanislav I. Tomarev
-
Unlocking extracellular vesicle-mediated efficient DNA delivery for long-lasting transgene expression
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Melissa Tan, Yumi Kawamura, Carol Wang, Ryan Schneider, George Richards, Odom Seng, William Eagen, Dean Lee, Evonne Ip, Desmond Wai Loon Chin,...
-
Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosis
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Elizabeth M. Parzych, Mamadou A. Bah, Nicholas J. Tursi, Ebony N. Gary, Ali R. Ali, Jacqueline D. Chu, Rianne N. Esquivel, Debra K. Duso, Matthew...
-
Capless self-amplifying mRNA vaccine induces dose-sparing protective immunity against HPAI clade 2.3.4.4 H5 virus in mice
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Beom Kyu Kim, Ji-Hyun Park, Won-Suk Choi, Sol Oh, Se Hee An, Gi Chan Lee, Santosh Chokkakula, Chang-Ung Kim, Ju Hwan Jeong, Seong Cheol Min, Dong...
-
Tissue-specific silencing of synthetic mRNAs by de-targeting elements maps vaccination-competent tissues and allows Cas9 de-immunization
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Guendalina Froechlich, Annagiulia Scognamiglio, Simone Totaro, Linda Nocchi, Emilio Pellino, Andrea Campanile, Luigia Infante, Giulio Miano,...
-
Synchronized latency reversal and immune clearance by a multifunctional fusion protein enables HIV-1 reservoir reduction
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Fei Luo, Yinghui Cao, Na Liu, Xiaowei Wang, Wenjia Hu, Yajun Yan, Xiaoqing Xie, Dongmei Jiang, Yangyang Xu, Jun Wang, Hongyu Wang, Zhenyang Yu,...
-
Targeted antisense oligonucleotide therapy rescues PRPF31 expression in retinitis pigmentosa caused by a splicing mutation
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Poulami Banik, Felix Zimmann, Prasoon K. Thakur, Lubica Dudakova, Kateřina Večerková, Ondrej Kostov, Marvin H. Caruthers, Michal Kolář, Inka...
-
Prothrombin recognition and conformational modulation by anti-thrombin anticoagulant aptamers
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Romualdo Troisi, Alessandro Cangiano, Nathan Cowieson, Vera Spiridonova, Nicola Pozzi, Pompea Del Vecchio, Luigi Paduano, Filomena Sica
-
Repurposing triamterene as chloride intracellular channel 1 inhibitor via ligand-based approach for glioblastoma
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Federica Barbieri, Francesca Cianci, Beatrice Federica Tremonti, Irene Dellacasagrande, Alessandro Corsaro, Guido Rey, Stefano Thellung, Noemi...
-
Dysregulated proline metabolism contributes to retinal fibrosis in neovascular AMD: Therapeutic potential of prolyl-4-hydroxylase inhibition
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Yue Zeng, Ting Zhang, Elisa Cornish, So-Ra Lee, Michelle Yam, Mark Eminhizer, Jingwen Zeng, Jialing Zhang, Shaoxue Zeng, Azhar Dzulhadj B....
-
Targeting the MNK1-MYH9 axis blocks YAP1 recruitment to prevent thrombosis and platelet activation-induced NETosis
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Kang Liu, Xinke Fang, Jingjun Sheng, Zhiming Wang, Ruijuan Yin, Qi Yuan, Tianyu Wang, Shaoyun Zhou, Qisheng Ling, Haidong Chen, Muhammad Awais,...
-
A helicase-fused Cas9 improves large-size fragment knockin
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Duowei Zhao, Xiangjie Zhao, Yuhang Gao, Sujie Yang, Xiaochen Guo, Caiyan Zhang, Chuanpei Li, Chengda Zhang, Huan Tian, Qianqian Xu, Zhi Yin,...
-
Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Linda Zeng, Jingxian Shu, Shuping Zhong, Xin Dong, Yongjian Wu, Xi Huang
-
Targeting N 7 -methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Shenghua Zhu, Yifan Wu, Xinyue Zhang, Sui Peng, Han Xiao, Shuling Chen, Lixia Xu, Tianhong Su, Ming Kuang